Vila–Farres X et al. – Studies of mastoparan with time–killing curves showed bactericidal activity at MIC ×8 for both colistin–susceptible and colistin–resistant A. baumannii. In conclusion, mastoparan may be a potential alternative for the treatment of colistin–resistant A. baumannii infections.
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor